Home/Filings/4/0001601830-24-000070
4//SEC Filing

Dar Zavain 4

Accession 0001601830-24-000070

CIK 0001601830other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 6:11 PM ET

Size

7.3 KB

Accession

0001601830-24-000070

Insider Transaction Report

Form 4
Period: 2024-06-03
Dar Zavain
Director
Transactions
  • Award

    Class A Common Stock

    2024-06-03+13,097102,153 total
  • Award

    Stock Option (Right to Buy)

    2024-06-03+26,19326,193 total
    Exercise: $8.59Exp: 2034-06-03Class A Common Stock (26,193 underlying)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 3, 2025 or the day prior to the Issuer's 2025 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer.
  • [F2]The shares subject to this option will vest and become exercisable on the earlier of June 3, 2025 or the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer.

Issuer

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830

Entity typeother

Related Parties

1
  • filerCIK 0001852075

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:11 PM ET
Size
7.3 KB